Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $98 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an Outperform rating on Merit Medical Systems (NASDAQ:MMSI) with a price target of $98.
April 16, 2024 | 3:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research maintains an Outperform rating on Merit Medical Systems with a $98 price target.
The reaffirmation of an Outperform rating and a $98 price target by Barrington Research suggests a positive outlook on Merit Medical Systems' stock. This endorsement from a reputable analyst could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100